Valuation: Universal Vision Biotechnology Co., Ltd.

Market Cap 10.68B 323M 290M 267M 242M 459M 30.28B 472M 3.2B 1.27B 16.22B 1.21B 1.19B 51.28B P/E 2026 *
9.35x
P/E 2027 * -
Enterprise Value 10.68B 323M 290M 267M 242M 459M 30.28B 472M 3.2B 1.27B 16.22B 1.21B 1.19B 51.28B EV / Sales 2026 *
2.51x
EV / Sales 2027 * 2.4x
Free-Float
47.64%
Yield 2026 *
6.38%
Yield 2027 * -
08-12 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-11 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-05 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-04 Universal Vision Biotechnology Co., Ltd. announces Annual dividend, payable on April 22, 2026 CI
11-12 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-08-12 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-13 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-03-05 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-03-05 Universal Vision Biotechnology Co., Ltd. announces Annual dividend, payable on April 21, 2025 CI
24-11-13 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
24-08-11 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
24-05-09 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
24-03-13 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
1 day+1.20%
1 week-1.95%
Current month-2.70%
1 month-5.26%
3 months-11.58%
6 months-4.91%
Current year-13.70%
1 week 115.5
Extreme 115.5
127.5
1 month 115.5
Extreme 115.5
134.5
Current year 115.5
Extreme 115.5
154
1 year 115.5
Extreme 115.5
161
3 years 115.5
Extreme 115.5
307
5 years 115.5
Extreme 115.5
432.08
10 years 18.64
Extreme 18.643305
432.08
Manager TitleAgeSince
Chief Executive Officer - 2010-01-31
Director of Finance/CFO - 2016-03-31
President - -
Director TitleAgeSince
Director/Board Member - 2003-06-01
Chairman - 2012-06-27
Director/Board Member 66 2012-06-27
Change 5-day change 1-year change 3-year change Capi.($)
+1.20%-1.95%-7.01%-58.42% 321M
-0.44%+0.41%-12.74%+16.90% 191B
-1.21%+2.55%+9.44%+43.47% 126B
-1.26%+3.38%-9.57%+17.33% 124B
-1.57%+1.82%-39.83%+7.26% 98.14B
+1.24%+2.64%-4.15%+76.90% 65.98B
-0.45%+8.03%+17.86%-8.77% 58.63B
-1.40%+3.57%-1.91%+62.35% 55.67B
+1.42%-5.09%-7.57%+50.74% 48.78B
+1.08%+3.41%+4.00%-4.71% 36.03B
Average -0.14%+2.29%-5.15%+20.31% 80B
Weighted average by Cap. -0.58%+2.53%-7.34%+27.19%

Financials

2026 *2027 *
Net sales 4.25B 129M 115M 106M 96.53M 183M 12.06B 188M 1.27B 507M 6.46B 483M 472M 20.42B 4.44B 134M 120M 111M 101M 191M 12.59B 196M 1.33B 530M 6.75B 504M 493M 21.33B
Net income 1.14B 34.55M 30.98M 28.55M 25.93M 49.07M 3.24B 50.44M 342M 136M 1.74B 130M 127M 5.49B -
Net Debt - -
Projected Income Statement - Annual - Universal Vision Biotechnology Co., Ltd.
Logo Universal Vision Biotechnology Co., Ltd.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD is a Taiwan-based company principally engaged in the trading of ophthalmic supplies and the provision of eye treatment and related medical services. The Company provides laser vision correction equipment and services, as well as the trading of medical drugs, optical glasses and contact lenses. In addition, the Company is involved in the leasing of medical places, the planning of clinic operation, as well as the provision of medical cosmetology services. The Company operates its businesses mainly in Taiwan market.
Employees
401
Date Price Change Volume
26-11-09 NT$126.00 +1.20% 90,919
26-11-09 NT$124.50 -1.58% 219,036
26-11-06 NT$126.50 +1.61% 413,893
26-11-05 NT$124.50 +0.40% 216,273
26-11-04 NT$124.00 -1.59% 289,642
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
MarketScreener Ratings - Universal Vision Biotechnology Co., Ltd.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
126.00TWD
Average target price
150.00TWD
Spread / Average Target
+19.05%
  1. Stock Market
  2. Stocks
  3. 3218 Stock